Inflammation

Cannabidiol as an emergent therapeutic strategy for lessening the impact of inflammation on oxidative stress

The endocannabinoid system: an emerging key player in inflammation

Anti-inflammatory role of cannabidiol and O-1602 in cerulein-induced acute pancreatitis in mice

Cannabinoids, endocannabinoids, and related analogs in inflammation

Cannabidiol, a non-psychotropic plant-derived cannabinoid, decreases inflammation in a murine model of acute lung injury: role for the adenosine A(2A) receptor

Cannabinoids suppress inflammatory and neuropathic pain by targeting α3 glycine receptors

Cannabidiol reduces intestinal inflammation through the control of neuroimmune axis

Diabetic retinopathy: Role of inflammation and potential therapies for anti-inflammation

Cannabidiol reduces Aβ-induced neuroinflammation and promotes hippocampal neurogenesis through PPARγ involvement

Cannabidiol attenuates high glucose-induced endothelial cell inflammatory response and barrier disruption

Vanilloid TRPV1 receptor mediates the antihyperalgesic effect of the nonpsychoactive cannabinoid, cannabidiol, in a rat model of acute inflammation

Cannabidiol attenuates cisplatin-induced nephrotoxicity by decreasing oxidative/nitrosative stress, inflammation, and cell death

Cannabinoids in clinical practice